Apellis Pharmaceuticals, Inc. (APLS)
USD 19.83
(-11.94%)
USD 19.83
(-11.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -241.37 Million USD | 45.03% |
| 2022 | -439.08 Million USD | -2.12% |
| 2021 | -429.97 Million USD | -128.65% |
| 2020 | -188.04 Million USD | 3.54% |
| 2019 | -194.95 Million USD | -30.64% |
| 2018 | -149.22 Million USD | 0.02% |
| 2017 | -149.25 Million USD | -500.29% |
| 2016 | -24.86 Million USD | 30.94% |
| 2015 | -36 Million USD | -164.29% |
| 2014 | -13.62 Million USD | -186.3% |
| 2013 | -4.75 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 113.08 Million USD | 8.92% |
| 2024 Q1 | 103.82 Million USD | 143.01% |
| 2024 Q3 | -285.39 Million USD | -34.93% |
| 2023 Q3 | -342.83 Million USD | 32.17% |
| 2023 Q4 | -241.37 Million USD | 29.6% |
| 2023 FY | -241.37 Million USD | 45.03% |
| 2023 Q1 | -653.21 Million USD | -48.77% |
| 2023 Q2 | -505.45 Million USD | 22.62% |
| 2022 Q2 | -393.18 Million USD | 7.06% |
| 2022 Q1 | -423.03 Million USD | 1.61% |
| 2022 FY | -439.08 Million USD | -2.12% |
| 2022 Q4 | -439.08 Million USD | 6.74% |
| 2022 Q3 | -470.81 Million USD | -19.74% |
| 2021 Q2 | 138.86 Million USD | -3.92% |
| 2021 Q3 | -71.91 Million USD | -151.79% |
| 2021 Q4 | -429.97 Million USD | -497.91% |
| 2021 FY | -429.97 Million USD | -128.65% |
| 2021 Q1 | 144.52 Million USD | 176.86% |
| 2020 Q3 | -42.67 Million USD | -195.07% |
| 2020 Q4 | -188.04 Million USD | -340.61% |
| 2020 FY | -188.04 Million USD | 3.54% |
| 2020 Q1 | -259.19 Million USD | -32.95% |
| 2020 Q2 | 44.89 Million USD | 117.32% |
| 2019 Q1 | -274.87 Million USD | -84.21% |
| 2019 FY | -194.95 Million USD | -30.64% |
| 2019 Q4 | -194.95 Million USD | 30.33% |
| 2019 Q3 | -279.82 Million USD | -1.52% |
| 2019 Q2 | -275.64 Million USD | -0.28% |
| 2018 Q2 | -227.07 Million USD | -79.77% |
| 2018 FY | -149.22 Million USD | 0.02% |
| 2018 Q4 | -149.22 Million USD | 22.98% |
| 2018 Q3 | -193.73 Million USD | 14.68% |
| 2018 Q1 | -126.31 Million USD | 15.37% |
| 2017 Q1 | 24.86 Million USD | 200.0% |
| 2017 Q3 | -13.13 Million USD | 74.83% |
| 2017 Q4 | -149.25 Million USD | -1036.23% |
| 2017 FY | -149.25 Million USD | -500.29% |
| 2017 Q2 | -52.18 Million USD | -309.89% |
| 2016 Q1 | 36 Million USD | 200.0% |
| 2016 Q4 | -24.86 Million USD | 0.0% |
| 2016 FY | -24.86 Million USD | 30.94% |
| 2015 FY | -36 Million USD | -164.29% |
| 2015 Q4 | -36 Million USD | -258.88% |
| 2015 Q3 | -10.03 Million USD | 32.51% |
| 2015 Q2 | -14.86 Million USD | 0.0% |
| 2015 Q1 | -14.86 Million USD | -9.12% |
| 2014 FY | -13.62 Million USD | -186.3% |
| 2014 Q1 | 4.75 Million USD | 0.0% |
| 2014 Q4 | -13.62 Million USD | 0.0% |
| 2013 FY | -4.75 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -331.482% |
| Alkermes plc | -166.73 Million USD | -44.76% |
| Agenus Inc. | 274.13 Million USD | 188.048% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 112.908% |
| Aptorum Group Limited | 1.35 Million USD | 17886.501% |
| Ardelyx, Inc. | 34.51 Million USD | 799.383% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5739.509% |
| Bicycle Therapeutics plc | -481.46 Million USD | 49.868% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 767.453% |
| ChromaDex Corporation | -24.04 Million USD | -903.705% |
| Chimerix, Inc. | -25.51 Million USD | -845.922% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3563.955% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -919.432% |
| CRISPR Therapeutics AG | -150.84 Million USD | -60.013% |
| Precision BioSciences, Inc. | -85.41 Million USD | -182.603% |
| Dyadic International, Inc. | -6.37 Million USD | -3684.372% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1414.912% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3249.002% |
| Lantern Pharma Inc. | -21.7 Million USD | -1012.141% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -118.362% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2725.308% |
| Incyte Corporation | -3.17 Billion USD | 92.398% |
| IO Biotech, Inc. | -140.69 Million USD | -71.551% |
| Jaguar Health, Inc. | 29.39 Million USD | 921.241% |
| Novavax, Inc. | -298.29 Million USD | 19.083% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4622.597% |
| Opthea Limited | 28.15 Million USD | 957.219% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1337.673% |
| ContextLogic Inc. | -232 Million USD | -4.039% |
| MiMedx Group, Inc. | -33.9 Million USD | -611.988% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2467.543% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -10317.272% |
| NextCure, Inc. | -6.47 Million USD | -3626.586% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -377.953% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3683.838% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2084.426% |
| Vaxcyte, Inc. | -368.22 Million USD | 34.45% |
| PDS Biotechnology Corporation | -32.7 Million USD | -637.937% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1496.985% |
| Pharming Group N.V. | 109.8 Million USD | 319.82% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1287.509% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -37.745% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1203.309% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1203.309% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3299.592% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4018.959% |
| Acelyrin, Inc. | -216.9 Million USD | -11.281% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4202.309% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -13900.638% |
| Summit Therapeutics Inc. | 34.67 Million USD | 796.115% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3448.008% |
| Senti Biosciences, Inc. | 1.74 Million USD | 13971.897% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -30.749% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -211.643% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3881.706% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 242029.858% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 38534.873% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -106.219% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -43.474% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 317.706% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3077.607% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -86.944% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3600.871% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 0.409% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1278.492% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 23.786% |
| MEI Pharma, Inc. | -3.7 Million USD | -6414.737% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2029.27% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 249.232% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 968.46% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3249.002% |
| Precigen, Inc. | -481 Thousand USD | -50081.081% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1814.161% |
| AlloVir, Inc. | -62.69 Million USD | -285.011% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -334.011% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 491.417% |
| ImmuCell Corporation | 10.99 Million USD | 2296.166% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -56.586% |
| Onconetix, Inc. | 5.33 Million USD | 4627.316% |
| PureTech Health plc | -167.19 Million USD | -44.363% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -692.42% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1162.533% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4816.908% |
| Seer, Inc. | -4.24 Million USD | -5592.712% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -904.164% |
| Innoviva, Inc. | 255.56 Million USD | 194.447% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -332.069% |
| ESSA Pharma Inc. | -33.62 Million USD | -617.905% |
| GlycoMimetics, Inc. | -40.98 Million USD | -488.933% |
| GT Biopharma, Inc. | -1.02 Million USD | -23540.646% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -256.094% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 494.03% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -80.021% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1641.996% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -736.004% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -320301.147% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -682.098% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2845.396% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -7613.954% |
| Soligenix, Inc. | -4.95 Million USD | -4774.609% |
| Century Therapeutics, Inc. | 847 Thousand USD | 28597.166% |
| Kura Oncology, Inc. | -20.11 Million USD | -1099.776% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -489.774% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2774.149% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 13349.803% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7449.922% |
| Autolus Therapeutics plc | -186.59 Million USD | -29.353% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -389.557% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 12.481% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 804.363% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 246.848% |
| GRI Bio, Inc. | -1.79 Million USD | -13354.348% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2586.962% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -625.775% |
| IGM Biosciences, Inc. | -72.6 Million USD | -232.439% |
| INmune Bio, Inc. | -25.41 Million USD | -849.868% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 259.9% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -376.462% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1385.417% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -8266.627% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 734.936% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -486.065% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 857.005% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 163.863% |
| Verastem, Inc. | -37.27 Million USD | -547.489% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2560.322% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -365.41% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1494.787% |
| Histogen Inc. | -7.48 Million USD | -3123.868% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1017.106% |
| Surrozen, Inc. | -32.66 Million USD | -638.951% |
| Organovo Holdings, Inc. | -1.5 Million USD | -15916.656% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5642.16% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1373.04% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 9326.72% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5907.772% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2779.927% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -455.617% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1555.85% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 23.807% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -33328.108% |
| Apollomics, Inc. | -27.39 Million USD | -781.077% |
| Amarin Corporation plc | -191.04 Million USD | -26.346% |
| Mesoblast Limited | 55.96 Million USD | 531.305% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1555.04% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -854.337% |
| Synaptogenix, Inc. | -28.66 Million USD | -742.144% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -25687.5% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 595.303% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -27898.385% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3221.887% |
| Exelixis, Inc. | -73.05 Million USD | -230.419% |
| Better Therapeutics, Inc. | -860 Thousand USD | -27966.395% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -905.168% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 32892.032% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3145.047% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 19348.086% |
| Gritstone bio, Inc. | 39.49 Million USD | 711.221% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -187.001% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -9070.143% |
| Avid Bioservices, Inc. | 169.72 Million USD | 242.21% |
| Insmed Incorporated | 721.62 Million USD | 133.448% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2540.384% |
| MediWound Ltd. | -5.32 Million USD | -4435.344% |
| OmniAb, Inc. | 9.2 Million USD | 2722.743% |
| Alector, Inc. | -35.63 Million USD | -577.304% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 380.759% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4797.95% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1923.182% |
| Zai Lab Limited | -775 Million USD | 68.855% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 170.876% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1021.352% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -192.642% |
| Immunic, Inc. | -45.34 Million USD | -432.358% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -24.924% |
| Veracyte, Inc. | -203.82 Million USD | -18.421% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 137.815% |
| FibroGen, Inc. | 56.76 Million USD | 525.196% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2810.511% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8437.814% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -11558.475% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.258% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -7124.514% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -45.436% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1451.31% |
| Galecto, Inc. | -21.21 Million USD | -1037.684% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -914.803% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 115.38% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -886.315% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1997.601% |
| XBiotech Inc. | -200.02 Million USD | -20.672% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -187.001% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5430.632% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -584.488% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -212.584% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4341.276% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -41.637% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -161.298% |
| Vaxxinity, Inc. | 10.13 Million USD | 2482.264% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 132.783% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2141.652% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -265.958% |
| NexImmune, Inc. | -3.13 Million USD | -7602.569% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6890.844% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1497.272% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -790.668% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2589.055% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -193655.569% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -494.92% |
| Ainos, Inc. | 4.07 Million USD | 6018.962% |
| Pluri Inc. | 22.82 Million USD | 1157.3% |
| Prothena Corporation plc | -608.34 Million USD | 60.323% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -103.25% |
| Celularity Inc. | 65.19 Million USD | 470.258% |
| Rallybio Corporation | -24.1 Million USD | -901.456% |
| Cue Biopharma, Inc. | -33.81 Million USD | -613.714% |
| MeiraGTx Holdings plc | -40.3 Million USD | -498.906% |
| Omeros Corporation | 331.17 Million USD | 172.883% |
| Humacyte, Inc. | -22.48 Million USD | -973.428% |
| Immunocore Holdings plc | -358.59 Million USD | 32.69% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -882.181% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -681.111% |
| Blueprint Medicines Corporation | 702.83 Million USD | 134.342% |
| CalciMedica, Inc. | -5.53 Million USD | -4264.756% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -28.239% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2263.139% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -502.87% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -625.862% |
| Pulmatrix, Inc. | -10.41 Million USD | -2217.087% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3938.33% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -532.822% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -116.667% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -302.661% |
| Cytokinetics, Incorporated | 642.37 Million USD | 137.575% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4045.131% |
| Nutriband Inc. | -251.65 Thousand USD | -95812.691% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -607.439% |
| Vor Biopharma Inc. | 4.3 Million USD | 5713.279% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.001% |
| Evogene Ltd. | -19.63 Million USD | -1129.352% |
| ProKidney Corp. | -56.23 Million USD | -329.211% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -395.913% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2513.036% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 117.697% |
| CorMedix Inc. | -43.05 Million USD | -460.643% |
| BioLineRx Ltd. | 7.33 Million USD | 3390.226% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -778.831% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 623.048% |
| Atai Life Sciences N.V. | -28.55 Million USD | -745.196% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 10921.245% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -957.902% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1460.987% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -221.511% |
| MediciNova, Inc. | -50.78 Million USD | -375.294% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -206.289% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1072898.444% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3640.685% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -20.794% |
| Biomea Fusion, Inc. | -166.57 Million USD | -44.907% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -34.863% |
| Mereo BioPharma Group plc | -51.46 Million USD | -368.964% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -154.493% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 17.834% |
| Absci Corporation | -72.59 Million USD | -232.476% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5386.268% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -2.958% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -156.203% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -152.227% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -517.744% |
| Allakos Inc. | -24.97 Million USD | -866.45% |
| Imunon, Inc. | -4.21 Million USD | -5628.037% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1537.302% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -78.265% |
| BioAtla, Inc. | -109.01 Million USD | -121.419% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 32892.032% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -25605.112% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2117.14% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1038.381% |
| XOMA Corporation | -29 Million USD | -732.314% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1357.554% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2577.141% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3140.314% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -93.661% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -15.952% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -195.15% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -160.202% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -27993.051% |
| Akari Therapeutics, Plc | -3.84 Million USD | -6177.529% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14972.912% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 117.48% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -20215.116% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5596.948% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 312.697% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 335514.524% |
| Orgenesis Inc. | 21.78 Million USD | 1208.02% |
| Entera Bio Ltd. | -10.62 Million USD | -2170.872% |
| GH Research PLC | -78.07 Million USD | -209.145% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -982.964% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -805.402% |
| Xencor, Inc. | 29.64 Million USD | 914.232% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -12153.504% |
| Replimune Group, Inc. | 1.41 Million USD | 17194.263% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -98455.784% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -90.932% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -20215.116% |
| Portage Biotech Inc. | -4.98 Million USD | -4745.834% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1072898.444% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -265.039% |
| OncoCyte Corporation | -6.56 Million USD | -3577.754% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 26996.312% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5198.286% |
| Purple Biotech Ltd. | -14.13 Million USD | -1607.25% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -916.042% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3587.869% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1346.014% |
| HilleVax, Inc. | -165.48 Million USD | -45.857% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -9410.284% |
| Tharimmune, Inc. | -10.93 Million USD | -2107.254% |
| Genprex, Inc. | -6.73 Million USD | -3482.432% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 34.554% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -172.859% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -17128.48% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -7176.905% |
| OKYO Pharma Limited | -826.84 Thousand USD | -29091.701% |
| Savara Inc. | 153 Thousand USD | 157858.824% |
| Curis, Inc. | -23.88 Million USD | -910.47% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4579.627% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -31004.029% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3788.064% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 20468.861% |
| BeiGene, Ltd. | -2.25 Billion USD | 89.287% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2056.243% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 60.314% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -30.059% |
| Erasca, Inc. | -37.21 Million USD | -548.568% |
| bluebird bio, Inc. | 108.57 Million USD | 322.316% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18641.541% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 163.729% |
| DBV Technologies S.A. | -126.98 Million USD | -90.077% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18641.541% |
| Moderna, Inc. | -2.9 Billion USD | 91.697% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2231.636% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2120.933% |
| Molecular Templates, Inc. | 707 Thousand USD | 34240.17% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -669.408% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 169.638% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -194.132% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -163.132% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -647.927% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -602.15% |
| MacroGenics, Inc. | -66.98 Million USD | -260.336% |
| RenovoRx, Inc. | -1.17 Million USD | -20477.238% |
| Adicet Bio, Inc. | -138.78 Million USD | -73.915% |
| Prime Medicine, Inc. | -27.94 Million USD | -763.86% |
| Aditxt, Inc. | 18.12 Million USD | 1432.004% |
| Adagene Inc. | -87.62 Million USD | -175.452% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5694.627% |
| Quantum-Si incorporated | -118.55 Million USD | -103.591% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 770.382% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3129.394% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -397.58% |
| SciSparc Ltd. | -2.06 Million USD | -11588.668% |
| Vericel Corporation | 1.27 Million USD | 19001.41% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1912.817% |
| Minerva Neurosciences, Inc. | 41 Million USD | 688.649% |
| Generation Bio Co. | 31.44 Million USD | 867.524% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -37.64% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -680.555% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 307.02% |
| Invivyd, Inc. | -198.47 Million USD | -21.612% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -167.388% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -9966.822% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -240.968% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3436.571% |
| 2seventy bio, Inc. | 181.71 Million USD | 232.829% |
| ADMA Biologics, Inc. | 90.06 Million USD | 367.993% |
| Clene Inc. | 3.34 Million USD | 7326.677% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2557.48% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1022.082% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3640.685% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 29.859% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -828.361% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 235.857% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5799.231% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4925.49% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4533.73% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -85.237% |
| Evaxion Biotech A/S | 5.28 Million USD | 4665.503% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -114.422% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -83.869% |
| Trevena, Inc. | 2.25 Million USD | 10789.593% |
| Surrozen, Inc. | -32.66 Million USD | -638.951% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -368.591% |
| Cingulate Inc. | 3.08 Million USD | 7929.9% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -8118.284% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3458.439% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2497.838% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -204.289% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -83.619% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -128.697% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6022.07% |
| Kronos Bio, Inc. | -36.05 Million USD | -569.471% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2665.32% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16653.496% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -344.874% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1774.28% |
| ImmunityBio, Inc. | 618.22 Million USD | 139.043% |
| Korro Bio, Inc. | -132.94 Million USD | -81.56% |
| Kineta, Inc. | -4.54 Million USD | -5215.371% |
| BioVie Inc. | -17.73 Million USD | -1261.19% |
| Codexis, Inc. | -43.27 Million USD | -457.812% |
| Celularity Inc. | 65.19 Million USD | 470.258% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7516.63% |
| Celcuity Inc. | 6.78 Million USD | 3658.203% |
| Virax Biolabs Group Limited | -3.36 Million USD | -7073.106% |
| Cibus, Inc. | -8.07 Million USD | -2888.004% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5607.52% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5381.641% |
| IN8bio, Inc. | -16.38 Million USD | -1372.762% |
| Kodiak Sciences Inc. | -103.87 Million USD | -132.367% |
| Annexon, Inc. | -193.75 Million USD | -24.575% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 670575.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1279.342% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6770.794% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 122.895% |
| Eyenovia, Inc. | 1.25 Million USD | 19276.183% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 997.123% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7342.831% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -625.993% |
| Arcellx, Inc. | -296.95 Million USD | 18.719% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1137.419% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -309.972% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1064.525% |
| Moolec Science SA | 117.61 Thousand USD | 205319.528% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -528.587% |
| Geron Corporation | 14.76 Million USD | 1735.194% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -536.56% |
| Royalty Pharma plc | 5.65 Billion USD | 104.266% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -70.676% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3353.375% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4400.79% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -71.512% |
| Humacyte, Inc. | -22.48 Million USD | -973.428% |
| Structure Therapeutics Inc. | -124.33 Million USD | -94.123% |
| 89bio, Inc. | -289.05 Million USD | 16.496% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -856.228% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -13437.353% |
| Genelux Corporation | -6.89 Million USD | -3398.637% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -677.137% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 388.725% |
| Notable Labs, Ltd. | -9.77 Million USD | -2369.016% |
| Liquidia Corporation | -80.17 Million USD | -201.051% |
| Mustang Bio, Inc. | -3.73 Million USD | -6360.68% |
| Immunovant, Inc. | -635.22 Million USD | 62.002% |
| Quantum-Si incorporated | -118.55 Million USD | -103.591% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1274.237% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5725.996% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3106.989% |
| Acasti Pharma Inc. | -23 Million USD | -949.211% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -7068.238% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1385.417% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -75.237% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -7645.281% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -985.692% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1199.86% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -42.589% |
| PepGen Inc. | -60.67 Million USD | -297.842% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -950.535% |
| United Therapeutics Corporation | -507.7 Million USD | 52.458% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1162.005% |
| Solid Biosciences Inc. | -47.75 Million USD | -405.489% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -27898.385% |
| Immuneering Corporation | -54.94 Million USD | -339.313% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5642.16% |
| Silo Pharma, Inc. | -3.52 Million USD | -6748.749% |
| Belite Bio, Inc | -87.27 Million USD | -176.576% |
| XOMA Corporation | -29 Million USD | -732.314% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -241.416% |
| Bionomics Limited | 227 Million USD | 206.326% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -107.574% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9429.056% |
| uniQure N.V. | -102.95 Million USD | -134.452% |
| Cassava Sciences, Inc. | -121.13 Million USD | -99.256% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5694.627% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 689.414% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1917.983% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7700.756% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 227808.491% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7342.831% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2810.511% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3154.733% |
| Altimmune, Inc. | -134.48 Million USD | -79.475% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 221.865% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9429.056% |
| Compugen Ltd. | -12.9 Million USD | -1770.513% |
| Peak Bio, Inc. | 10.34 Million USD | 2434.307% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -85190.106% |
| Benitec Biopharma Inc. | -50.58 Million USD | -377.188% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -131.336% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1328.664% |
| Zura Bio Limited | -99.8 Million USD | -141.84% |
| PolyPid Ltd. | 6.17 Million USD | 4012.01% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 425.649% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1328.664% |
| Instil Bio, Inc. | 75.35 Million USD | 420.299% |
| argenx SE | -2.02 Billion USD | 88.103% |
| Immunome, Inc. | -97.02 Million USD | -148.762% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -972.998% |
| Verona Pharma plc | -220.44 Million USD | -9.494% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -236.438% |
| Shattuck Labs, Inc. | -121.42 Million USD | -98.784% |
| CervoMed Inc. | -7.79 Million USD | -2997.341% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -30.12% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5419.575% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -83.218% |
| Moolec Science SA | 117.61 Thousand USD | 205319.528% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -10449.538% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1618.211% |
| AnaptysBio, Inc. | -18.15 Million USD | -1229.795% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1229.868% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -242.949% |
| NeurAxis, Inc. | 145.7 Thousand USD | 165763.006% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2248.958% |
| Lumos Pharma, Inc. | -28.49 Million USD | -747.124% |
| Achilles Therapeutics plc | -126.92 Million USD | -90.17% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -236.438% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -36709.51% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1061.9% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16653.496% |
| Nutriband Inc. | -251.65 Thousand USD | -95812.691% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1732.594% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3144.234% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 170.95% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1116.941% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 46.059% |
| Palisade Bio, Inc. | -12.06 Million USD | -1900.92% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -72.026% |
| Beam Therapeutics Inc. | -262.72 Million USD | 8.127% |
| Neurogene Inc. | -131.95 Million USD | -82.919% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1206.394% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4846.127% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 36.008% |
| Sesen Bio, Inc. | -112.55 Million USD | -114.451% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -141.709% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -10180.762% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -518.488% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -189.824% |
| Athira Pharma, Inc. | -88.99 Million USD | -171.206% |
| Vaccinex, Inc. | -1.28 Million USD | -18639.984% |
| HCW Biologics Inc. | 2.85 Million USD | 8549.366% |
| XOMA Corporation | -29 Million USD | -732.314% |
| Nektar Therapeutics | 210.24 Million USD | 214.807% |
| Arvinas, Inc. | -313.8 Million USD | 23.081% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14972.912% |
| Merus N.V. | -192.88 Million USD | -25.138% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 502.386% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3378.971% |
| Rezolute, Inc. | -68.16 Million USD | -254.083% |
| Clene Inc. | 3.34 Million USD | 7326.677% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1730.371% |
| BeyondSpring Inc. | -13.75 Million USD | -1654.787% |
| Synlogic, Inc. | -6.68 Million USD | -3510.636% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 21384.921% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2754.772% |
| Peak Bio, Inc. | 10.34 Million USD | 2434.307% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -192.855% |
| Krystal Biotech, Inc. | -350.23 Million USD | 31.083% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 294.458% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -42.826% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -7545.233% |
| MannKind Corporation | 143.89 Million USD | 267.736% |
| Ikena Oncology, Inc. | -109.15 Million USD | -121.125% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3088.099% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -629.218% |
| Gossamer Bio, Inc. | 180.35 Million USD | 233.831% |
| CohBar, Inc. | -5.93 Million USD | -3969.836% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -711.386% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5386.268% |
| Legend Biotech Corporation | -949.39 Million USD | 74.576% |
| Mural Oncology plc | -255.84 Million USD | 5.657% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 849.25% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -5023.951% |
| Disc Medicine, Inc. | -358.28 Million USD | 32.631% |
| Champions Oncology, Inc. | 4.81 Million USD | 5116.022% |
| REGENXBIO Inc. | 54.76 Million USD | 540.715% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -89660.029% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -59.823% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2578.327% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -199.16% |
| Vaxart, Inc. | -8.24 Million USD | -2828.904% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -381.011% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -89.808% |
| Cellectis S.A. | -43.85 Million USD | -450.384% |
| Longeveron Inc. | -2.9 Million USD | -8200.241% |
| Repare Therapeutics Inc. | -107.85 Million USD | -123.786% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 124.925% |
| Inozyme Pharma, Inc. | 12 Million USD | 2110.755% |
| Revolution Medicines, Inc. | -608.2 Million USD | 60.314% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -19523.659% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 8.957% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -60.837% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1442.602% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -32517.703% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.476% |
| Denali Therapeutics Inc. | -74.86 Million USD | -222.408% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1912.817% |
| Veru Inc. | 4.77 Million USD | 5149.635% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2046.283% |
| Cingulate Inc. | 3.08 Million USD | 7929.9% |
| Passage Bio, Inc. | 4.58 Million USD | 5364.362% |
| Context Therapeutics Inc. | -14.44 Million USD | -1570.408% |
| Exicure, Inc. | 5.84 Million USD | 4226.705% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -4.773% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -509.985% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1638.277% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -310.348% |
| Nuvalent, Inc. | -335.38 Million USD | 28.032% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 14017.159% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -224.066% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2615.084% |
| OmniAb, Inc. | 9.2 Million USD | 2722.743% |
| Anew Medical, Inc. | 1.43 Million USD | 16950.045% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1573.414% |
| Lipocine Inc. | -4.75 Million USD | -4976.587% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -119.772% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1684.735% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -376.462% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1069.673% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3491.296% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -266.675% |
| Ocugen, Inc. | -32.52 Million USD | -642.2% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -182.058% |
| Q32 Bio Inc. | -37.94 Million USD | -536.057% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -38334.873% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1684.101% |
| Equillium, Inc. | -22.39 Million USD | -977.934% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -844.036% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -639.794% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -97260.386% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 280.071% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 7647.561% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 73589.911% |
| Dominari Holdings Inc. | 195 Thousand USD | 123880.0% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4482.782% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2606.863% |
| Bio-Techne Corporation | 267.74 Million USD | 190.149% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1389.117% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -104.389% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2772.438% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1807.92% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 1.529% |
| Nkarta, Inc. | 57.29 Million USD | 521.248% |
| BioCardia, Inc. | 212 Thousand USD | 113954.245% |
| Iterum Therapeutics plc | 13.43 Million USD | 1896.182% |